Advertisement Cardiac Safety Consulting - Development of Strategic Cardiac Safety Plans - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
close icon

Provider of Technology and Services

More info about

Cardiac Safety Consulting – Development of Strategic Cardiac Safety Plans

ERT’s cardiology team is available to consult and provide strategic value on study design, as well as medical and regulatory issues. With more than 70 years of combined industry and regulatory experience, the team is led by two of the most highly regarded thought leaders in the industry: ERT’s chairman and chief scientific officer Joel Morganroth, M.D., F.A.C.C. and ERT’s executive vice president and chief medical officer, Jeffrey S. Litwin, M.D. F.A.C.C.

For more information please see our website, or contact us.

 

Quick Contact Cardiac Safety Consulting – Development of Strategic Cardiac Safety Plans